Here are five takeaways:
1. The company saw a 34 percent increase in 2017 year-end sales, from $1.4 million in 2016 to more than $1.9 million in 2017.
2. Safe Orthopaedics reported revenues reaching just over $3.8 million for the year, a 37 percent increase from the prior year.
3. As of Dec. 31, 2017, the company had $4.5 million in available cash. In 2016, the company had $4.4 million in cash.
4. Along with strong sales and revenue growth, Safe Orthopaedics expanded into Germany in 2017. The company also saw rapid expansion in Latin America.
5. The company also shuffled up its leadership in 2017 by hiring additional sales directors and representatives.
More articles on devices and implants:
Global spinal implants and devices market to expand at 6.1% CAGR, reach $21B by 2025 — 4 insights
DJO Global, NuVasive, Stryker & more: 18 device company notes
Boston Scientific earns FDA approval for Spectra WaveWriter SCS System — 5 notes
